Industry News

MEDIPOST America clears Phase 1/2 IND for the U.S. clinical trial on stem cell drug for lung
Merck's new tool in cancer fight
ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent - Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent
United States : FDA Approves Baxter's HYQVIA for Treatment of Adults with Primary Immunodeficiency
FDA denies Amarin appeal, stock plunges
Lilly Announces CYRAMZA Phase III Meets Primary Endpoint Of Overall Survival; FDA Advisory Committee to Review Natpara Biologics License Application-Halts NPS Pharma Trading
FDA Approves Baxter�s HYQVIA for Treatment of Adults with Primary Immunodeficiency
FDA Advisory Committee Recommends Approval of Natpara� for Long-Term Treatment of Hypoparathyroidism
Acadia Pharmaceuticals: FDA Grants Trade Name Nuplazid for Pimavanserin
Hospira Issues a Voluntary Nationwide Recall of One Lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), In 0.9% Sodium...
Rutgers Receives $10 Million Pledge to Advance Treatment of Cancer Patients
United States : Baxter Announces Baxalta as the Name of the New Global Biopharmaceutical Company
California biotech firm to hire 100-plus to make cancer drugs in University Research Park
Covidien Acquires Sapheon
WholeHealth Products announces the release of the FDA Cleared "Troponin I" rapid test
Teva Launches SYNCare Home Administration Support Program for Patients on SYNRIBO Omacetaxine Mepesuccinate for Injection Teva
ConvaTec Introduces New Urostomy Pouch Designed for Unmatched Comfort, Discretion and Security Pouch System with Moldable Technology for Clinically Proven Leak and Skin Protection
Cantrell Drug Company Enhances Compounding Safety with Closed Vial Filling System from Aseptic Technologies
Lilly receives European marketing OK for insulin
ConvaTec Introduces New Urostomy Pouch Designed for Unmatched Comfort, Discretion and Security Pouch System with Moldable Technology� for Clinically Proven Leak and Skin Protection
FDA allows marketing of the first test to assess risk of developing acute kidney injury
Marathon Pharmaceuticals Launches ZiNGO (lidocaine hydrochloride monohydrate) Powder Intradermal Injection System, Topical Local Anesthetic to Manage Venous Access Pain
New drug-free device meets unmet need
Merck Secures FDA Approval of Keytruda
AbbVie sued by FTC for paying to delay generic drug